Information  X 
Enter a valid email address
  Print          More announcements

Tuesday 14 September, 2021

QIAGEN N.V.

Release of a capital market information

DGAP Post-admission Duties announcement: QIAGEN N.V. / Share Repurchase
QIAGEN N.V.: Release of a capital market information

14.09.2021 / 10:21
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated EU Regulation 2016/1052 / Share Repurchase - Interim Reporting

With disclosure dated July 20, 2021, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no 2016/1052 the immediate beginning of a first tranche of up to USD 100 million under the share repurchase program originally announced on July 12, 2021.

The number of shares which have been bought back within the framework of such tranche of the share repurchase program in the time period from August 30, 2021 until and including September 10, 2021, amounts to 163,292 shares.

Shares were bought back as follows:

Date Number of Shares acquired Average Price (EUR) Purchased Volume (EUR)
6- September -2021 32,136 47.5168 1,526,999.88
7- September -2021 30,435 47.4511 1,444,174.23
8- September -2021 36,789 47.5057 1,747,687.20
9- September -2021 32,000 47.2564 1,512,204.80
10- September -2021 31,932 47.0360 1,501,953.55
Total 163,292 47.3570 7,733,019.66
 

The underlying individual trades are published on the website of QIAGEN N.V. (http://corporate.qiagen.com/investor-relations/share-information/share-buyback).

The total number of shares which have already been bought back within the framework of such tranche of the share repurchase program from July 20, 2021 until and including September 10, 2021 amounts to 1,340,113 shares.

The purchase of the shares of QIAGEN N.V. was carried out by a financial institution that has been commissioned by QIAGEN N.V.

Venlo, 14 September 2021

Managing Board

###
Contacts:

QIAGEN

Investor Relations   Public Relations  
John Gilardi +49 2103 29 11711 Dr. Thomas Theuringer +49 2103 29 11826
e-mail: [email protected]   e-mail: [email protected]  


14.09.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
Netherlands
Internet: www.qiagen.com

 
End of News DGAP News Service

1233160 14.09.2021 

fncls.ssp?fn=show_t_gif&application_id=1233160&application_name=news&site_id=financialexpress

a d v e r t i s e m e n t